Studies have shown that keloid cells express high levels of MMP1 and MMP3, which can promote scar formation by regulating the cell matrix, whereas AD-MSC-EVs can inhibit the expression of MMP1 and MMP3 to a certain extent and reduce the degradation of the peripheral cytoplasmic matrix, reducing scar formation [71]. The gene discussed is MMP3; the disease is keloid.